NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Notably, Nrf2 signaling is largely impaired in the liver of rodents with NAFLD and was associated with increased generation of ROS and inflammatory cytokines, reduced levels of antioxidant enzymes, impaired hepatic FA oxidation, enhanced lipogenesis, and increased lipid accumulation and steatosis [16].